EWING, NJ, March 26, 2018 -- TGI SOLAR POWER GROUP INC. (OTC Markets: TSPG) (“TGI”), a diversified technology company, would like to take this opportunity to provide a corporate update to its shareholders and interested parties. On March 22, 2018 TGI & Data Boss issued joint announcement regarding change in capital structure of Data Boss. We would like to take this opportunity to clear the issue, changes only apply to Data Boss corporation, not TGI Solar Power Group Inc.
Data Boss is planning to develop cyber security tools that empower companies and individuals to take control of their own online data, crypto wallet, software and systems needed to keep information secure.
About Data Boss: Data Boss (http://databosscorp.com) offers development and consulting services that address IT requirements like architecture and development of enterprise business systems, enterprise performance monitoring, business intelligence and enterprise application integration. Data Boss addresses the enterprise-wide end-to-end needs of organizations with its comprehensive range of solutions and services for large-scale ERP applications, sophisticated Database requirements, Business Intelligence (BI) and Agile SOA implementation; that includes Enterprise Applications (EA), Business Process Management (BPM), Enterprise Performance Management (EPM) and Governance. Data Boss provides services to its Fortune 100 and medium sized clients in varied verticals spanning from Healthcare to Financials. Data Boss Technologies, Microsoft Technologies, cutting edge Mobile technologies including iPhone, Android and Windows platforms, Fusion Middleware and core Database Technology based on Oracle Applications.
For more information please see www.otcMarkets.com under ticker symbol "TSPG", and visit our Facebook page https://www.facebook.com/TGISolarPower/
About TGI Solar: TGI SOLAR POWER GROUP INC. is a diversified holding company. TGI's strategy is to acquire innovative and patented technologies, components, processes, designs and methods with commercial value that will give competitive market advantage and generate shareholder value.
Safe Harbor Statements under the Private Securities Litigation Reform Act of 1965: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements. Such statements include, but are not limited to, certain delays that are beyond the company's control, with respect to market acceptance of new technologies, or product delays in the testing and evaluation of products, and other risks, as detailed in the company's periodic filings with the Securities and Exchange Commission.
For further info [email protected] 609-201-2099


SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Jetstar to Charge for Overhead Cabin Bags From February
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



